Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Disease Understanding / Natural History
Disease population comorbidity / comedication profile
Disease prevalence / Incidence
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Clinical Trial Protocol Feasibility (evaluate inclusion / exclusion criteria using RWE)
Assess background adverse event rates in disease population
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Evaluating standards of care
Protocol Development / Feasibility for post-marketing safety / efficacy studies
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Drug safety monitoring (insights into high risk
sub-populations)
Treatment patterns
Off-label use
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Pre-clinical / Discovery /
Early phase
Clinical
Development
Peri-Approval
Post-
Marketing
Commercial, HEOR
Drug Launch Evaluation (market share, prescribers, population)
Cost effectiveness, burden of illness